Home › NCT06653400

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy: a Randomized Controlled Trial

Who can join

Ages 18 and older · Women · Healthy volunteers welcome

Inclusion Criteria:

* Patients assigned female at birth,
* booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates.

Exclusion Criteria:

* Allergy to ketorolac or non-steroidal anti-inflammatory medications
* Allergy to lidocaine
* Presence of thrombocytopenia
* Contraindications to lidocaine
* History of gastritis or gastric ulcer
* Acute renal failure or chronic renal disease
* Chronic liver disease
* History of bleeding diathesis
* Long term narcotic use

About the study

A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.

What is being tested

• paracervical block (procedure)
• Lidocaine (drug)
• ketorolac (drug)

Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 60 · Started: Feb 27, 2025

Contact the study team

• Kathleen E Ackert, DO · Phone: 212-241-4500

Official record on ClinicalTrials.gov — NCT06653400

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.